| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/28/2005 | WO2005068623A1 Method of screening remedy for rheumatoid arthritis |
| 07/28/2005 | WO2005068618A1 Polynucleotides encoding novel ubch10 polypeptides and kits and methods using same |
| 07/28/2005 | WO2005068505A1 Fusion protein comprising tatdmt polypeptide |
| 07/28/2005 | WO2005068504A1 Inflammatory cytokine inhibitor |
| 07/28/2005 | WO2005068501A1 Methods and compositions for modulating a steroid receptor |
| 07/28/2005 | WO2005068498A2 Human therapeutic cells secreting nerve growth factor |
| 07/28/2005 | WO2005068497A1 Iis: a novel ifn-gamma-inducible protein, member of the secretoglobin family, that modulates cellular invasion and migration |
| 07/28/2005 | WO2005068494A2 Chimera botulinum toxin type e |
| 07/28/2005 | WO2005068491A1 Antitumoral and antiviral peptides |
| 07/28/2005 | WO2005068020A1 High-density lipoprotein coated medical devices |
| 07/28/2005 | WO2005067981A1 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine |
| 07/28/2005 | WO2005067972A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/28/2005 | WO2005067970A1 Iron supplement and utilization of the same |
| 07/28/2005 | WO2005067967A1 Methods of using botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion) |
| 07/28/2005 | WO2005067965A2 Use of protein products for preventing and treating pancreatic diseases and/or obestiy and/or metabolic syndrome |
| 07/28/2005 | WO2005067964A1 A method of reducing serum proinsulin levels in type 2 diabetics |
| 07/28/2005 | WO2005067963A1 Use of polyethylene glycol-modified interferon-alpha in therapeutic dosing regimens |
| 07/28/2005 | WO2005067962A2 Composition derived from milk goat comprising growth factors and oligosaccharides |
| 07/28/2005 | WO2005067961A1 Methods for treating vascular disorders |
| 07/28/2005 | WO2005067960A1 HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS |
| 07/28/2005 | WO2005067959A1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| 07/28/2005 | WO2005067958A2 Methods and compositions for the inhibition of cathepsins |
| 07/28/2005 | WO2005067957A2 Use of a dg147 protein product for preventing and treating metabolic disorders |
| 07/28/2005 | WO2005067956A2 Use of interleukin-21 for the treatment of autoimune diseases and allograft rejection |
| 07/28/2005 | WO2005067950A1 Kava-kava extract for reducing the toxic and side effects and composition comprising the same and preparation thereof |
| 07/28/2005 | WO2005067942A1 Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| 07/28/2005 | WO2005067912A1 Method of intentionally, noninvasively, therapeutically modulating fat in a living mammal |
| 07/28/2005 | WO2005067900A2 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 07/28/2005 | WO2005067898A2 Improved sustained release compositions for pulmonary administration of insulin |
| 07/28/2005 | WO2005067890A2 Controlled release cgrp delivery composition for cardiovascular and renal indications |
| 07/28/2005 | WO2005067889A1 Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh |
| 07/28/2005 | WO2005067500A2 Enhancement of immune responses |
| 07/28/2005 | WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads |
| 07/28/2005 | WO2005056024A9 Methods of enhancing stem cell engraftment |
| 07/28/2005 | WO2005051988A3 Compositions and methods for the treatment of systemic lupus erythematosis |
| 07/28/2005 | WO2005051433B1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 07/28/2005 | WO2005051410A9 Hepatitis c virus inhibitors |
| 07/28/2005 | WO2005048982A3 Efficient introduction of an aerosol into a ventilator circuit |
| 07/28/2005 | WO2005044839A3 Stabilized alpha helical peptides and uses thereof |
| 07/28/2005 | WO2005039627A3 Therapeutic applications for c-peptide |
| 07/28/2005 | WO2005032469A3 METHODS FOR REGULATING BUD-HYPHA TRANSITION AND cAMP LEVELS IN CANDIDA ALBICANS |
| 07/28/2005 | WO2005030239A3 Antitumor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor |
| 07/28/2005 | WO2005030126A3 Adhesin-specific nanoparticles and process for using same |
| 07/28/2005 | WO2005027710A3 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 07/28/2005 | WO2005017163A3 Phenotypic knockout of cell-surface proteins |
| 07/28/2005 | WO2005014035A3 Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
| 07/28/2005 | WO2005009366A3 Restoring vascular function |
| 07/28/2005 | WO2005003300A3 Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| 07/28/2005 | WO2005003289A3 Ap1 amine oxidase variants |
| 07/28/2005 | WO2005001033A3 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 07/28/2005 | WO2004112724A3 Compositions for and methods for treating hiv |
| 07/28/2005 | WO2004110388A3 Sigma ligands for neuronal regeneration and functional recovery |
| 07/28/2005 | WO2004110362A3 Immunotherapeutics for biodefense |
| 07/28/2005 | WO2004087734A3 Stq-peptides |
| 07/28/2005 | WO2004069870B1 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 07/28/2005 | WO2004064767A3 Nitric oxide inducing agents |
| 07/28/2005 | WO2004058946A3 Protein arrays |
| 07/28/2005 | WO2004053093A3 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 07/28/2005 | WO2004031206A8 Products for regulating the degradation of collagen and methods for indentifying same |
| 07/28/2005 | WO2004002296A3 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 07/28/2005 | WO2003103597A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 07/28/2005 | WO2003092618A3 Materials and methods for prevention and treatment of rna viral diseases |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2002097036A3 Compositions and methods for adipose abundant protein |
| 07/28/2005 | WO2002080758A3 Methods for treating drug addiction |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165889 System and method for monitoring and analyzing internet traffic |
| 07/28/2005 | US20050165488 Medical implants and anti-scarring agents |
| 07/28/2005 | US20050165467 Intravascular devices and fibrosis-inducing agents |
| 07/28/2005 | US20050165348 Needleless syringe using supersonic gas flow for particle delivery |
| 07/28/2005 | US20050165224 Inhibition of penicillin resistance in s. pneumoniae |
| 07/28/2005 | US20050165215 Peptide synthesis and deprotection using a cosolvent |
| 07/28/2005 | US20050165098 Local anesthetic methods and kits |
| 07/28/2005 | US20050165097 Comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist, for reversing local anesthesia |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050164968 RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA) |
| 07/28/2005 | US20050164967 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA) |
| 07/28/2005 | US20050164966 Aging, cancer, autoimmune diseases, inflammatory/allergic diseases |
| 07/28/2005 | US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 07/28/2005 | US20050164953 Beta-secretase inhibitors |
| 07/28/2005 | US20050164952 Delivery system for growth hormone releasing peptides |
| 07/28/2005 | US20050164951 Inhibitors for the soluble epoxide hydrolase |
| 07/28/2005 | US20050164950 Orally administered small peptides synergize statin activity |
| 07/28/2005 | US20050164949 Renal failure, nephropathy, patent ductus arteriosus, a congenital heart disease; peptide contain the amino acid 4,4'-biphenylalanine; kit for assaying bioactivity of EP4 |
| 07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
| 07/28/2005 | US20050164947 Administering a peptide having isozyme-specific inhibitory activity for epsilon PKC; intracellular drug delivery by conjugation to carrier polyarginine peptide; drug abuse of nicotine, opioid, narcotic or (ethyl) alcohol |
| 07/28/2005 | US20050164945 Endotheliase-1 ligands |
| 07/28/2005 | US20050164944 Promoting osteodifferentiation by coating a substrate with a solution of a synthetic peptide having -Ile-Ala residues folded in a beta-bend and mimics cell binding by collagen, incorporation into a biocompatible gel, exposure to cells; hard and soft tissue repair |
| 07/28/2005 | US20050164943 Purified polypeptide consisting of asn-cys-glu-his-phe-val-thr-tyr-cys-arg-tyr-gly (NCEHFVTYCRYG) amino acid sequence; may be part of a fusion protein or conjugated to an agent that increases potency and/or specificity; anticarcinogenic agents; melanomas |
| 07/28/2005 | US20050164942 Administering a peptide having the amino acid sequence Tyr-D-Leu-Phe-Ala-Asp-Val-Ala-Ser-Thr-Ile-Gly-Asp-Phe-Phe-His-Ser-Ile-NH2 to treat viral infections; inflammation, reaction to toxin of ethanol, lead, carbon tetrachloride or acetaminophen, or from trauma resulting in ischemia; reperfusion injuries |
| 07/28/2005 | US20050164938 Prevention of neuron cell death in mammals wherein said neural cells express an OP/BMP-activated serine/threonine kinase receptor and a GDNF/NGF-activated tyrosine kinase receptor |
| 07/28/2005 | US20050164937 Growth factor homolog zvegf4 |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164935 Therapeutic chemokine receptor antagonists |
| 07/28/2005 | US20050164934 Novel genes associated with the maintenance of differentiation of smooth muscle cells |
| 07/28/2005 | US20050164933 Method of reducing injury to mammalian cells |
| 07/28/2005 | US20050164932 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants |
| 07/28/2005 | US20050164931 contains 118 amino acids; glycoproteins; immunomodulatory activity; can activate RAW 264.7 macrophage and mouse spleen cell, enhance the production of TNF-alpha and nitric oxide by RAW 264.7 macrophages; induce cell proliferation and IFN-gamma secretion by mouse splenocytes |
| 07/28/2005 | US20050164929 Methods of preventing and treating inflammatory bowel disease |